AveXis Seeks FDA Blessing to Manufacture AVXS-101 Gene Therapy to Treat SMA Type 1 Babies – SMA News Today
SMA News Today |
AveXis Seeks FDA Blessing to Manufacture AVXS-101 Gene Therapy to Treat SMA Type 1 Babies
SMA News Today Specifically, AveXis wants the FDA to approve its manufacturing process for AVXS-101, its SMA gene therapy, at the May 1 meeting, and to assure the regulatory body that the drug's quantity and quality is sufficient to meet demand. AveXis hopes to … |
